Related Experiment Video
Updated: May 29, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022
Choroidal neovascularization of optic disk melanocytoma treated with bevacizumab
Taro Kamisasanuk1, Eisuke Uchino, Taiji Sakamoto
1Department of Ophthalmology, Faculty of Medicine, Kagoshima University Graduate School of Medicine and Dental Sciences, Kagoshima, Japan.
Purpose:
To report a case of choroidal neovascularization (CNV) associated with optic disk melanocytoma successfully treated with bevacizumab.
Methods:
A 63-year-old man complained of visual impairment in his left eye. His visual acuity was 0.9 OS. Fundus examination showed optic disk melanocytoma associated with serous retinal detachment and mild hemorrhage. Fluorescein and indocyanine green angiography revealed CNV adjacent to the optic disc. Intravitreous bevacizumab (IVB) was performed 3 times.
Results:
Choroidal neovascularization and serous retinal detachment disappeared at 5 months after IVB. Visual acuity recovered to 1.5 OS and has been stable for 1 year follow-up. No adverse events were found related to IVB.
Conclusions:
Intravitreous bevacizumab can be a beneficial treatment for CNV associated with optic disc melanocytoma.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy